Adia Med Inc (ADIA)
OTC Markets OTCQB
Fundamentals
Valuation and ratings
Adia Med Inc trades at USD0.16. We do not hold enough of the inputs to run a discounted cash flow on this company, so we publish no fair value for it rather than a number we would not defend.
About Adia Med Inc
Adia Med Inc offers medical treatments and nutritional supplements. The company operates in three segments: Biolete, Adia Med, and Adia Labs. It provides autologous hematopoietic stem cell transplantation (AHSCT) treatments for multiple sclerosis patients. The company also operates Adia Med, a clinic to perform stem cell treatments, and Adia Labs, which procures and sells stem cell products to outside clinics or Adia Med. In addition, the company offers nutritional supplements and biologic products. It sells its products on a direct-to-consumer basis, as well as through other direct to consumer channels. The company was formerly known as Adia Nutrition, Inc. and changed its name to Adia Med Inc in June 2026. Adia Med Inc is based in Winter Park, Florida.
The full research page for ADIA, with financial statements, ownership detail, peer comparison and alerts, is free inside the app.
Data from company filings, exchange quotes and SEC EDGAR 13F disclosures. Quotes are delayed. Metrics we do not have are left out rather than estimated. Educational information, not financial advice.